Table 2.
Associations Between Treatment Site and End-of-Life Medical Care
Intensive Carea | Hospice Servicesb | Other EOL Carec | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Treatment Site | No./Total | % | OR | 95% CI | No./Total | % | OR | 95% CI | No./Total | % | OR | 95% CI |
Yale Cancer Center | 9/75 | 12.0 | 3.14 | 1.16-8.47d | 37/75 | 49.3 | 0.52 | 0.29-0.92d | 29/75 | 38.7 | 0.63 | 0.34-1.15 |
Simmons Comprehensive Cancer Center |
3/33 | 9.1 | 2.30 | 0.58-9.16 | 20/33 | 60.6 | 0.64 | 0.29-1.38 | 10/33 | 36.4 | 0.69 | 0.31-1.55 |
New Hampshire Oncology-Hematology |
0/66 | 0 | – e | – e | 50/66 | 75.8 | 1.66 | 0.85-3.24 | 16/66 | 24.2 | 1.24 | 0.63-2.45 |
Parkland Hospital | 8/128 | 6.3 | Ref | Ref | 84/128 | 65.6 | Ref | Ref | 36/128 | 28.1 | Ref | Ref |
EOL indicates end of life; OR, odds ratio; CI, confidence interval; Ref, referent category.
Defined as the receipt of cardiopulmonary resuscitation and/or mechanical ventilation followed by death in an intensive care unit.
Included patients who died either at home while receiving hospice services or in an inpatient hospice (n=40/191).
Other EOL care included inpatient hospital care (n=58; 5 patients received care in an intensive care unit and then were transferred to a hospital floor before death), home care without hospice services (n=20), and inpatient nursing home care (n=13).
P <.05 (significant).
No cases.